Ask Our Doctors and Nurses!

HEPARIN Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

HEPARIN Safety Reports

Total HEPARIN reports: 259.
HEPARIN FDA safety alerts: 2002 2005 2006 2007 .
Reported deaths: 40    Reported hospitalizations: 122.
Take HEPARIN Side Effects Survey or Share Your HEPARIN Story. Read More Here.

Showing 1-75 of 259 Next >

Consumer or non-health professional from CANADA reported HEPARIN problem on Apr 09, 2007. Female patient was diagnosed with surgical vascular shunt and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemothorax. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Consumer or non-health professional from CANADA on Apr 09, 2007. Female patient was diagnosed with venous thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemothorax. HEPARIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported HEPARIN problem on Apr 17, 2007. Female patient, 90 years of age, weighting 163.0 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haemoglobin decreased, occult blood positive, retroperitoneal haemorrhage. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Consumer or non-health professional from SPAIN on Apr 17, 2007. Female patient, 77 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, heparin-induced thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with BICARBONATE, ENOXAPARIN. Patient recovered.

Consumer or non-health professional from SPAIN reported HEPARIN problem on Apr 17, 2007. Female patient, 77 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, heparin-induced thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with BICARBONATE, ENOXAPARIN. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Apr 23, 2007. Female patient, 53 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia, pulmonary embolism. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Apr 20, 2007. Male patient, 67 years of age, was diagnosed with carotid endarterectomy and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: procedural complication, prothrombin time abnormal. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Male patient was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. HEPARIN dosage: unknown. During the same period patient was treated with DEXTROSE. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Apr 26, 2007. Male patient, 49 years of age, was diagnosed with deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Apr 26, 2007. Male patient, 86 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported HEPARIN problem on Apr 16, 2007. Male patient, 64 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, heparin-induced thrombocytopenia, peritoneal haemorrhage, post procedural complication, splenic haemorrhage, splenic infarction, splenic rupture, thrombosis. HEPARIN dosage: unknown. During the same period patient was treated with FRESH FROZEN PLASMA, PHYTONADIONE. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Dec 29, 2005. Female patient, 76 years of age, weighting 173.0 lb, was diagnosed with atrial fibrillation and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: therapeutic response decreased. HEPARIN dosage: unknown. During the same period patient was treated with CARDIZEM, ACETYLSALICYLIC ACID SRT, TYLENOL, COUMADIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on May 04, 2007. Male patient, 49 years of age, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia test. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on May 10, 2007. Male patient, 58 years of age, weighting 280.0 lb, was diagnosed with peripheral vascular disorder and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, atrial fibrillation, deep vein thrombosis, dialysis, disease progression, gangrene, heparin-induced thrombocytopenia, ischaemia, peripheral artery aneurysm. HEPARIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on May 14, 2007. Male patient, 63 years of age, was diagnosed with acute myocardial infarction, atrial fibrillation and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, heparin-induced thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 14, 2007. Male patient, 51 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: blood potassium increased. HEPARIN dosage: unknown. During the same period patient was treated with LINEZOLID, MORPHINE, MOVICOL, NYSTATIN, OMEPRAZOLE, PARACETAMOL, PROPOFOL, RIFAMPICIN. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on May 15, 2007. Male patient, weighting 205.0 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Health Professional from UNITED STATES on May 17, 2007. Male patient, 67 years of age, weighting 217.6 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage. HEPARIN dosage: 1000U/HR,@10ML/HR,INTRAVEN. During the same period patient was treated with FUROSEMIDE, LISINOPRIL, VITAMIN CAP, DIGOXIN, VITAMIN D, CALCIUM CARBONATE, ACETAMINOPHEN. Patient recovered.

Physician from UNITED STATES reported HEPARIN problem on May 07, 2007. Male patient, 64 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, abdominal tenderness, activated partial thromboplastin time prolonged, arrhythmia, atrial fibrillation, blood pressure decreased, body temperature increased, cardiac tamponade, coagulopathy. HEPARIN dosage: unknown. During the same period patient was treated with WARFARIN, PHYTONADIONE. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Physician from UNITED STATES on May 07, 2007. Male patient, 64 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood pressure decreased, haemoglobin decreased, heparin-induced thrombocytopenia, international normalised ratio increased, splenic rupture, splenic vein thrombosis. HEPARIN dosage: unknown. During the same period patient was treated with WARFARIN, PHYTONADIONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ITALY reported HEPARIN problem on Sept 15, 2006. Male patient, 63 years of age, was diagnosed with aortic valve replacement and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis, circulatory collapse, heparin-induced thrombocytopenia, multi-organ failure, myocardial infarction, ventricular dysfunction. HEPARIN dosage: unknown. Patient died.

HEPARIN problem was reported by a Consumer or non-health professional from ITALY on Sept 15, 2006. Male patient, 58 years of age, was diagnosed with coronary artery bypass, preoperative care and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cardiac tamponade, heparin-induced thrombocytopenia, ischaemia, osteomyelitis, sepsis, thrombosis. HEPARIN dosage: unknown. During the same period patient was treated with CARVEDILOL, ENALAPRIL MALEATE, FUROSEMIDE, ASPIRIN. Patient died.

Pharmacist from UNITED STATES reported HEPARIN problem on May 25, 2007. Female patient, 71 years of age, weighting 154.3 lb, was diagnosed with coronary artery bypass, intravenous catheter management and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardiac failure congestive, coronary artery disease, cyanosis, disseminated intravascular coagulation, embolism, lung disorder, renal disorder, renal failure acute. HEPARIN dosage: unknown. During the same period patient was treated with AMIODARONE, LASIX, SYNTHROID. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Male patient, 59 years of age, weighting 212.0 lb, was diagnosed with myocardial infarction and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, myocardial infarction. HEPARIN dosage: unknown. Patient was hospitalized. Patient died on 06/15/2006.

Consumer or non-health professional from UNITED STATES reported HEPARIN problem on May 31, 2007. Male patient, 35 years of age, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: endocrine disorder, heparin-induced thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Health Professional from UNITED STATES on July 21, 2006. Male patient, 78 years of age, was diagnosed with catheterisation cardiac and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with WARFARIN, METOPROLOL SUCCINATE, FUROSEMIDE, CAPTOPRIL, ISOSORBIDE MONONITRATE, DIGOXIN, ALENDRONATE, CALCIUM CARBONATE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported HEPARIN problem on Mar 22, 2007. Female patient, 51 years of age, was diagnosed with prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: arteriovenous fistula site haematoma. HEPARIN dosage: unknown. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Female patient, 36 years of age, was diagnosed with prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: injection site haematoma. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HEPARIN problem on May 22, 2007. Female patient, child 7 years of age, was diagnosed with central venous catheterisation and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. HEPARIN dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on June 07, 2007. Female patient, 33 years of age, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: retroperitoneal haemorrhage. HEPARIN dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, FLUCONAZOLE, PIPERACILLIN AND TAZOBACTAM, METRONIDAZOLE, PANTOPRAZOLE, OCTREOTIDE ACETATE, METHYLPREDNISOLONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HEPARIN problem on June 05, 2007. Male patient, weighting 4.41 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: circulatory collapse, group b streptococcus neonatal sepsis, pneumonia, pulmonary hypertension. HEPARIN dosage: unknown. During the same period patient was treated with AMPICILLIN, GENTAMICIN, OXYGEN. Patient died on 02/21/2007.

HEPARIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Male patient, weighting 4.41 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: circulatory collapse, group b streptococcus neonatal sepsis, pneumonia, pulmonary hypertension. HEPARIN dosage: unknown. During the same period patient was treated with AMPICILLIN, GENTAMICIN, OXYGEN. Patient died on 02/21/2007.

Health Professional from ITALY reported HEPARIN problem on June 01, 2007. Female patient, 19 years of age, weighting 176.4 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: femoral nerve palsy, post procedural haematoma. HEPARIN dosage: unknown. During the same period patient was treated with ENOXAPARIN. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on June 08, 2007. Male patient, weighting 190.0 lb, was diagnosed with aortic aneurysm repair, thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia, venous thrombosis. HEPARIN dosage: unknown. During the same period patient was treated with LOVENOX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported HEPARIN problem on June 11, 2007. Female patient was diagnosed with colonoscopy and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: diverticulitis, haematochezia, international normalised ratio increased, intestinal polyp. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on June 12, 2007. Female patient, 69 years of age, weighting 124.6 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: diverticulitis, gastrointestinal haemorrhage, haematochezia, polyp. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on June 14, 2007. Female patient, 65 years of age, weighting 246.9 lb, was diagnosed with pulmonary embolism and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with LIPIDS, LEVOPHED, LEVAQUIN, ZOSYN, PEPCID, REGLAN, LANTUS. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on June 18, 2007. Female patient, child 4 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. HEPARIN dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported HEPARIN problem on July 05, 2006. Female patient, weighting 119.9 lb, was diagnosed with deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, overdose. HEPARIN dosage: 760ML/HR, OVER 39MIN, CONTINUOUS, INTRAVENOUS. Patient recovered.

HEPARIN problem was reported by a Health Professional from UNITED STATES on Sept 28, 2006. Male patient was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: bleeding time prolonged, overdose. HEPARIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported HEPARIN problem on June 11, 2007. Male patient, 58 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: antithrombin iii deficiency, axillary vein thrombosis, bronchial carcinoma, cardiac tamponade, heparin-induced thrombocytopenia, international normalised ratio increased, pneumonia, protein c deficiency, protein s deficiency. HEPARIN dosage: unknown. During the same period patient was treated with WARFARIN, DANAPAROID. Patient was hospitalized. Patient died.

HEPARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2007. Male patient, 22 years of age, was diagnosed with deep vein thrombosis, pulmonary embolism and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. HEPARIN dosage: unknown. During the same period patient was treated with COUMADIN, STEROIDS. Patient died on 06/03/2002.

Health Professional from CANADA reported HEPARIN problem on May 16, 2007. Male patient, 47 years of age, was diagnosed with percutaneous coronary intervention and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, cerebrovascular accident, injection site haemorrhage, mouth haemorrhage, myocardial infarction, thrombocytopenia, thrombosis. HEPARIN dosage: unknown. During the same period patient was treated with ASPIRIN, PLAVIX, INTEGRILIN. Patient was hospitalized and became disabled. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on June 27, 2007. Male patient, 69 years of age, was diagnosed with prophylaxis, deep vein thrombosis, pulmonary embolism and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on July 06, 2006. Male patient, 73 years of age, was diagnosed with pulmonary embolism and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: retroperitoneal haematoma. HEPARIN dosage: 1250 U /25 ML /HR CONTINOUS IV DRIP. During the same period patient was treated with ACETAMINOPHEN, ALBUTEROL SPIROS, CIPROFLOXACIN IN DEXTROSE, FENTANYL CITRATE, SYRINGE LEUR, HYDROCORTISONE SUCCINATE, HUMULIN R. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on July 05, 2006. Male patient, 83 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis, thrombocytopenia. HEPARIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on July 05, 2006. Female patient, 70 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: antibody test positive, atrial thrombosis, heparin-induced thrombocytopenia test, mass. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on July 10, 2006. Male patient, 63 years of age, was diagnosed with thrombosis prophylaxis, wound infection and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: antibody test positive, heparin-induced thrombocytopenia test. HEPARIN dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, ACETAMINOPHEN, ASCORBIC ACID, CLOTRIMAZOLE, CYANOCOBALAMIN, ENALAPRIL MALEATE, ETODOLAC, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on July 12, 2006. Male patient, 63 years of age, was diagnosed with pulmonary embolism and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, haematocrit decreased. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on July 13, 2006. Male patient, 54 years of age, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported HEPARIN problem on July 18, 2006. Female patient, 54 years of age, weighting 145.0 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, implant site thrombosis, post procedural complication. HEPARIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on July 19, 2006. Male patient was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, condition aggravated, heparin-induced thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with ASPIRIN, FERROUS SULPHATE, FINASTERIDE, FUROSEMIDE, PSYLLIUM, TERAZOSIN. Patient was hospitalized. Patient died on 05/16/2006.

Pharmacist from UNITED STATES reported HEPARIN problem on July 24, 2006. Male patient was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage, nervous system disorder. HEPARIN dosage: unknown. Patient was hospitalized. Patient died on 05/02/2006.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on July 25, 2006. Male patient was diagnosed with aortic stenosis, coronary artery disease, myopathy and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on July 25, 2006. Female patient was diagnosed with aortic valve stenosis, heart valve replacement, mitral valve stenosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: antibody test positive, deep vein thrombosis, heparin-induced thrombocytopenia test, post procedural complication. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on July 24, 2006. Male patient was diagnosed with postoperative care and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage, nervous system disorder. HEPARIN dosage: unknown. Patient was hospitalized. Patient died on 05/04/2006.

Pharmacist from UNITED STATES reported HEPARIN problem on July 25, 2006. Female patient was diagnosed with coronary artery disease and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: post procedural haemorrhage, thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on July 25, 2006. Male patient was diagnosed with abdominal distension, gallbladder non-functioning, gastrointestinal necrosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia, post procedural complication. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on July 25, 2006. Male patient was diagnosed with acute myocardial infarction and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Physician from INDIA on July 12, 2006. Female patient, 50 years of age, weighting 88.18 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, electrocardiogram qt prolonged, haemodynamic instability, heart rate decreased, hypocalcaemia, procedural complication, procedural hypotension. HEPARIN dosage: unknown. During the same period patient was treated with FENTANYL, PROPOFOL, ROCUONIUM, ISOFLURANE, VECURONIUM BROMIDE, ATENOLOL, LOSARTAN POSTASSIUM, VALPROATE. Patient recovered.

Physician from JAPAN reported HEPARIN problem on July 13, 2006. Male patient, 56 years of age, was diagnosed with coronary angioplasty and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: angina pectoris, coronary artery occlusion, coronary artery stenosis, electrocardiogram q waves, electrocardiogram st segment elevation, electrocardiogram t wave inversion, heparin-induced thrombocytopenia, intracardiac thrombus. HEPARIN dosage: unknown. During the same period patient was treated with ASPIRIN, TICLOPIDINE, CILOSTAZOL. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Health Professional from KOREA, REPUBLIC OF on July 13, 2006. Male patient, 68 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. HEPARIN dosage: unknown. Patient recovered.

Health Professional from KOREA, REPUBLIC OF reported HEPARIN problem on July 13, 2006. Male patient, 50 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, intracranial haematoma. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Health Professional from KOREA, REPUBLIC OF on July 13, 2006. Female patient, 53 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cerebral haematoma, condition aggravated. HEPARIN dosage: unknown. Patient recovered.

Health Professional from KOREA, REPUBLIC OF reported HEPARIN problem on July 13, 2006. Female patient, 63 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, intracranial haematoma. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Physician from CANADA on July 18, 2006. Male patient, 72 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: carotid artery stenosis, cerebral infarction, chest pain, heparin-induced thrombocytopenia, post procedural complication, thrombotic stroke. HEPARIN dosage: unknown. During the same period patient was treated with ASPIRIN, CLOPIDOGREL. Patient recovered.

Physician from JAPAN reported HEPARIN problem on July 18, 2006. Female patient, 75 years of age, weighting 119.0 lb, was diagnosed with pulmonary embolism and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, cardiac failure, disease progression, disseminated intravascular coagulation, embolism, fibrin d dimer increased, gangrene, hemiparesis. HEPARIN dosage: unknown. During the same period patient was treated with WARFARIN, FUROSEMIDE, ATRIAL NATRIURETIC, IMMUNE CELLS. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Physician from CANADA on May 23, 2005. Female patient, 43 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia, thrombotic stroke. HEPARIN dosage: unknown. During the same period patient was treated with CLOPIDOGREL, ASPIRIN. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Aug 07, 2006. Female patient was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cardiac procedure complication. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Health Professional from UNITED STATES on July 25, 2006. Female patient, 79 years of age, weighting 323.0 lb, was diagnosed with aortic valve replacement and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: anti-platelet antibody, cardiac failure congestive, dermatitis bullous, ecchymosis, gastrointestinal haemorrhage, heparin-induced thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, AMIODARONE, IPRATROPIUM BROMIDE, ALBUTEROL, FOLIC ACID, LEVOTHYROXINE, LOTRIMIN, WARFARIN. Patient was hospitalized. Patient recovered.

Physician from CANADA reported HEPARIN problem on June 24, 2005. Female patient was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: anaphylactoid reaction, heparin-induced thrombocytopenia, injection site inflammation. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Physician from ISRAEL on Aug 01, 2006. Female patient, 20 years of age, was diagnosed with angiogram and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, acute respiratory distress syndrome, arterial thrombosis, auricular swelling, cerebral venous thrombosis, ear pain, grand mal convulsion, haemodialysis. HEPARIN dosage: unknown. During the same period patient was treated with AMLODIPINE, WARFARIN, ENALAPRIL MALEATE. Patient was hospitalized and became disabled. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on July 28, 2006. Male patient, 48 years of age, was diagnosed with pulmonary embolism, glioblastoma multiforme and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: brain oedema, cerebral haematoma, deep vein thrombosis, pulmonary embolism. HEPARIN dosage: unknown. During the same period patient was treated with GLIADEL, GLIASITE BALLOON WITH SALINE, STEROIDS. Patient was hospitalized. Patient died on 05/15/2006.

HEPARIN problem was reported by a Health Professional from UNITED KINGDOM on July 31, 2006. Male patient, 73 years of age, was diagnosed with haemodialysis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: accidental exposure, acute respiratory distress syndrome, anaphylactoid reaction, angiopathy, blood pressure immeasurable, cardiac arrest, device malfunction, heparin-induced thrombocytopenia, hypotension. HEPARIN dosage: unknown. During the same period patient was treated with ACTIVASE. Patient died.

Pharmacist from UNITED STATES reported HEPARIN problem on Aug 16, 2006. Male patient, 82 years of age, weighting 148.8 lb, was diagnosed with dialysis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, hypersplenism, ischaemic hepatitis, laboratory test abnormal, platelet count decreased, purpura, transfusion reaction. HEPARIN dosage: 5000 UNIT/ML 1.8ML ORT. During the same period patient was treated with CEFAZOLIN, INSULIN, COMBIVENT, XALATAN, METOPROLOL TARTRATE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Showing 1-75 of 259 Next >